

Az oldal teljes tartalmának és szolgáltatásainak eléréséhez regisztráció és belépés szükséges.
Amennyiben kérdése van, kérjük írja meg! Kérdésére hamarosan választ kap. Kérdése közvetlenül nem kerül fel az oldalra, de név nélkül -hogy mások is elolvashassák, szeretnénk ha felkerülhetne. Ezt a kérdés beküldésekor kérjük közölje.
Kérdés beküldése
1. Akingbola OA, Dervant MG, Custer JR, Palmisano JM. Noninvasive Bi-Level Positive Pressure Ventillation: Management of Two Pediatric Patients. Respir Care 1993; Vol 38, No. 10
2. Ambrosino N, Callegari G, Galloni C, Brega S, Pinna G. Cilinical evaluation of oscillating positive exspiratory pressure for enhancing expectoration in disease other then other than cystic fibrosis. Monaldi Arch Chest Dis 1995;50:269-275
3. American Thoracic Society. Standardizartion of spirometry 1994. Am J Respir Crit Care Med 1995;152:1107-1136
4. Apor P. Rehabilitációs edzésporogramok belbetegségekben. Orvosi Hetilap 1999; 140:579-585
5. Apor P, Borka P. Tréningprogramok a krónikus obstruktív tüdőbetegségekben. 1999 Medicina Thoracalis 1999;52 112-117
6. App EM, Kieselmann R, Reinhardt D. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy. Flutter versus autogenic drainage. Chest 1998;114:171-177
7. Arens R, Gozal D, Omlin KJ. Comparison of high-frequency chest compression and conventional chest physiotherapy in hospitalized patients with cystic fibrosis. Am J Respir Crit Care Med 1994;150:1154-1157
8. Asmus M, Bosschaerts M, Chevaillier J, Chevaillier V, Franckx H, Masson M, Pat K. Airway clearance techniques in children from 3-7 years. 1997
9. Aurora P, Whitehead B, Wade A et al. Lancet 1999; 354:1591-1593
10.Baldwin DR, Hill AL, Peckham DG, Knox AJ. Effect of addition of exercise to chest physiotherapy on sputum expectoration and lung function in adults with cystic fibrosis. Respiratory Medicine 1994;88:49-53
11.Bals R, WangX, Wu Z, Freeman T, Bafna V, Zasloff M, Wilson JM. Human b-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 1998;102:874-880
12.Boat TF, Welsh MJ, Beaudet AL. Cystic Fibrosis. In: Scriver CR, Beaudet AL, Sly WS. The metabolic Basis of Inherited Disease. 6th ed. New York, NY: McGraw-hill;1989;2:2649-2680
13.Borka P, Apor P. Inhalation and exercise in cystic fibrosis. 22. European CF Conference -Berlin 1998 Jun. 13-19
14.Brand PLP, Ent CK. The practical application and interpretation of simple lung function tests in CF. J R Soc Med 1999; 92(Suppl 37):2-12
15.Brochard L, Isabey D, Piquet J, Amaro P, Mancebo J, Messadi AA, Brun-Buisson C, Rauss A, Lemaire F, Harf A. Reversal of acute exacerbations of chronic obstructive lung disease by inspiratory assistance with a face mask. New England Journal of Medicine 1990;323:1523-1530
16.Bhuyan U, Peters AM, Gordon I, Davies H, Helms P. Effects of posture on the distribution of pulmonary ventilation and perfusion in children and adults. Thorax 1989; 44:480-484
17.Borsje P, Jongste JC, Mouton JW, Tiddens H. Aerosol therapy in cystic fibrosis: A survey of 54 CF centers. Pediatr Pulmonol 2000;30:368-376
18.Britto MT, Garrett JM, Konrad TR, Majure M, Leigh MW. Comparison of physical activity in adolescent with cystic fibrosis versus age-matched controls. Pediatr Pulmonol. 2000;30:86-91
19.Brochard L, Isabey D, Piquet J, Amaro P, Mancebo J, Messadi A-A, Brun-Buisson C, Rauss A, Lemaire F. Reversal of Acute Exacerbations of Chronic Obstructive Lung Disease by Inspiratory Assistance with Face Mask. N Engl J Med 1990; 323:1523-30
20.Carr L, Pryor JA, Hodson ME. Self chest clapping. Patients' views and the effects on oxygen saturation. Physiotherapy 1995;81:753-757
21.Cegla UH, Retzow A. Physiotherapy with the VRP1 for chronic obstructive pulmonary disease - Results of a multicenter comparative study. Pneumologie 1993;47:636-639
22.Cegla UH, Bautz M, Fröde G, Werner Th. Physiotherapie bei Patienten mit COAD und tracheobronchialer Instabilitat - vergleich zweier oszillierender PEP-systeme (RC-Cornet, VRP1 Desitin) Pneumologie 1997;51:129-136
23.Chevaillier J. Autogen drainage. (AD). In: Physiotherapy in the treatment of cystic fibrosis (CF). International Physiotherapy Group for Cystic Fibrosis (IGG/CF). 1995;pp.9-12
24.Chevaillier J, Eynden DV, Ginderdeuren F. Autogen drainage; An airway clearance technique. 1997
25.Dauletbaev N, Viel K, Behr J, Loitsch S, Buhl R, Wagner TO, Bargon J. Effects of short term inhaled fluticasone on oxidative burst of sputum cells in cystic fibfrosis patients. Eur Respir J 1999;14(5):1150-1155
26.David A. Autogenic drainage - the German approach. In: Pryor JA, ed. Respiratory Care. Edinburgh, Churchill Livingstone, 1991;p.65
27.Davidson AGF, Mcllwaine PM, Wong LTK, Nakielna M, Pirie GE. Physiotherapy in cystic fibrosis: a comparative trial of positive exspiratory pressure, autogenic drainage and conventional percussion and drainage techinques. Pediatr Pulmonol 1998;Suppl. 2,132
28.Eber E, Oberwaldner B, Zach MS. Airway obstruction and airway wall instability in cystic fibrosis: The isolated and Combined effect of theophylline and sympathomimetics. Pediatr Pulmonol 1988;4:205-212
29.Eng PA, Morton J, Douglass JA, Reidler J, Wilson J, Robertson CF. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatr Pulmonol 1996;21 (2), 77-83
30.Fiel SB. Clinical managementof pulmonary disease in cystic fibrosis. Lancet. 1993;341:1070-1074
31.Freitag L, Bremme J, Schroer M. High frequency oscillation for respiratory physiotherapy. Br J Anaesth 1989; 63:44s-46s
32.Fuch HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW. Effect of aerosolized recombinant human Dnase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 1994;331:637-642
33.Gallon A. Evaluation of chest percussion in the treatment of patients with copious sputum production. Respir Med 1991;85:45-51
34.Gallon A. The use of percussion. Physiotherapy 1992;78:85-89
35.Gaskell, D.V., Webber, B. A. The Bromptom Hospital Guide to Chest Physiotherapy. 4th ed. Blackwell Scientific Publications, Oxford 1980, pp. 13-30
36.Gaskin L, Corey M, Shin J, ReismanJJ, Thomas J, Tullis DE. Long term trial of conventional postural drainage and percussion versus positive exspiratory pressure. Pediatr Pumonol 1998; Suppl. 17,345
37.Giles DR, Wagener JS, Accurso FJ, Butler-Simon N. Short-term effects of postural drainage with with clapping versus autogenic drainage on oxygen saturation and sputum recovery in patients with cystic fibrosis. Chest 1995;108:952-954
38.Girard JP, Terki N. The Flutter VRP1: A new personal pocket therapeutic device used as an adjunct to drug therapy in the management of bronchial asthma. J Invest Allergol Clin Immunol 1994;4:23-27
39.Goldman MJ, Anderson GM, Stolzenberg ED, Kari UP, Zasloff M, Wilson JM. Human b-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 1997;88:553-560
40.Gyurkovits K. A cystás fibrosisról az ezredforduló küszöbén. Gyermekgyógyászati Szemle 2000; 3: 101-104
41.Hansen LG, Warwick WJ, Hansen KL. Mucus transport mechanisms in relation to the effect of high frequency chest compression (HFCC) on mucus clearance. Pediatr Pulmonol 1994;17:113-118
42.Harms HK, Matouk E, Tournier G at al. Multicenter, open-label study of recombinant human Dnase in cystic fibrosis patients with moderate lung disease. pediatr Pulmonol. 1998;26:155-161
43.Henke KG, Regniss JA, Bye PTP. Benefits of Continuous Positive Airway Pressure (CPAP) during Exercise in Cystic Fibrosis and Relationship to Disease Severity. Am Rev Respir Dis 1993;148:1272-1276
44.Henry RL, Gibson PG, Carty K, Cai Y, Francis JL. Airway inlammation after treatment with aerosolized desoxyribonuclease in cystic fibrosis. Pediatr Pulmonol 1998;26(2):97-100
45.Hodson ME, Madden BP, Steven MH, Tsang VT, Yacoub MH. Non-invasive mechanical ventilation for cystic fibrosis patients - a potential bridge to transplantation. Eur. Respir. J. 1991, 4, 524-527
46.Hodson ME, Warner JO. Respiratory problems and their treatment. Br.Med Bull. 1992;48:931-948
47.Hodson ME, Shan PL. Dnase trials in cystic fibrosis. Eur Respir J 1995;8:1786-914
8.Hofmeyr JL, Webber BA, Hodson ME. Evaluation of positive exspiratory pressure as an adjunct to chest physiotherapy in the treatment of cystic fibrosis. Thorax 1986;41:951-954
49.Homnick DN,White F, de Castro C. Comparison of an intrapulmonary percussive ventilator to standard aerosol and chest physiotherapy in treatment of cystic fibrosis. Pediatr Pulmonol 1995;20:50-55
50.Homnick DN, Anderson K, Marks JH. Comparison of the flutter device to standard chest physiotherapy in hospitalized patients with cystic fibrosis: a pilot study. Chest 1998;114:993-997
51.Johnson BD, Beck KC, Zeballos RJ, Weismann IM. Advances in pulmonary laboratory testing. Chest 1999;116:1377-1387
52.Johnson CA, Butler SM, Konstan MW, Breen TJ, Morgan WJ. Estimating effectiveness in an observational study: A case study of dornase alfe in cystic fibrosis. J Pediatr 1999;134:734-739
53.Khan Y, Manzur AZ, Hasson N, Heckmatt JZ, Dubowitz V. Effect of nasal ventillation on nocturnal hypoxaemia in neuromuscular patients. Am Rev Respir Disease 1992;4:145
54.Kieselmann R. Modified AD (M AD). In: Physiotherapy in the treatment of cystic fibrosis (CF). International Physiotherapy Group for Cystic Fibrosis (IPG/CF), 1995;pp.13-14
55.Kluft J, Beker L, Castagnino M, Gaiser J, Chaney H, Fink RJ. A comparison of bronchial drainage treatments in cystic fibrosis. Pediatr Pulmonol 1996;22:271-274
56.Konstan MW, Stern RC, Doershuk CF. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis. J Pediatr. 1994;124:689-693
57.Köhler E, Sollich V, Schuster R, Hühnerbein J. Lung deposition in CF patients using ultrasonic or jet nebulising. XIII. Intern. Cystic Fibrosis Congress Abstract Book 2000;144
58.Langenderfer B. Alternatives to percussion and postural drainage. A review of mucus clearance therapies: pecussion and postural drainage, autogenic drainage, positive exspiratory pressure, flutter valve, intrapulmonary percussive ventilation, and f high-frequency chest compression with the ThAIRapyvest. J Card Pulm Rehabil 1998;18:283-289
59.Lannefors L. Different ways of using positive exspiratory pressure to loosen and mobilize pulmonary secretion. Pediatr. Pulmonol. Suppl. 1992;8:136-7
60.Lannefors L. What are the alternatives? 2. Autogenic Drainage and Active Cycle of Breathing Techniques. Pediatric Pulmonol. Suppl. 1993; 9:95-96
61.Lapin CD. Conventional postural drainage and percussion- is this still the gold standard? - Against Pediatr Pulmonol Suppl. 1994;10:87-88
62.Lindemann H, Boldt A, Kieselmann R. Autogenic drainage: efficacy of a simplified method. Acta Univ Carol (Med) (Praha) 1990;36: 210-212
63.Lorin MI, Denning CR. Evaluation of postural drainage by measurement of sputum volume and consistency. AM J Phys Med 1971;50:215-219
64.Lyons E, Chatham K, Campbell IA, Presscott RJ. Evaluation of the Flutter VRP1 device in young adults with cystic fibrosis. Thorax 1992; 47:237P
65.Macmahon C. Breathing and physical exercises for use in cases of wounds in the pleura, lung and diaphragm. Lancet 1915;2:769-770
66.Magyar P, Hutás I, Vastag E. 1998 Pulmonológia 19.o. ISBN 963 242 133 7
67.McDonnel T, McNicholas WT, FitzGerald MX. Hypoxaemia during chest physiotherapy in patients with cyistc fibrosis. Ir J Med Sci 1986;155:345-348
68.Mcllwaine PM, Wong LTK, Peacock D, Davidson AGF. Long term comparative trial of conventional postural drainage and percussion versus positive exspiratory pressure physiotherapy in the treatment of cystic fibrosis. J Pediatr 1997;131:570-574
69.Mcllwaine PM, Wong LTK, Peacock D, Davidson AGF. "Flutter versus PEP": a long-term comparative trial of positive exspiratory pressure (PEP) versus oscillating positive exspiratory pressure (Flutter) physiotherapy techniques. Pediatr Pulmonol 1997; Suppl. 14, 299
70.Mead J, Turner JM, Macklem PT, et al. Significance of the relationship between lung recoil and maximum exspiratory flow. J Appl Physiol. 1967. 22:95-108
71.Miller S, Hall DO, Clayton CB, Nelson R. Chest physiotherapy in cystic fibrosis: a comparative study of autogenic drainage and the active cycle of breathing techniques with postural drainage. Thorax 1995;50:165-169
72.Mitchell I, Nakielna E, Tullis E, Adair C. Cystic Fibrosis End-stage care in Canada. Chest 2000; 118:80-84
73.Nelson R, Miller S, Hall D, Clayton B. Chest physiotherapy in cystic fibrosis. Thorax 1995;50:1123-1124
74.Oberwaldner B, Evans JC, Zach MS. Forced exspirations against a variable resistance: a new chest physiotherapy method in CF. Pediatr Pulmonol 1986; 2 358-367
75.Oberwaldner B, Theisl B, Rucker A, Zach M Chest physiotherapy in hospitalized patients with CF: a study of lung function effects and sputum production. Eur Respir J 1991, 4, 152-158
76.Oberwaldner B. Physiotherapy for airway clearance in paediatrics. Eur Respir J 2000; 15:196-204
77.Ojeniyi B, Frederiksen B, Hoiby N. Pseudomonas aureginosa cross-infection among patients with cystic fibrosis. Pediatr Pulmonol. 200;29:177-181
78.Padman R, Nadkarni VM, Nessen SV, Goodill J. Noninvasive Positive Pressure Ventillation in End-Stage Cystic Fibrosis: A Report of Seven Cases. Respir Care 1994;39(7):736-739
79.Pennock BE, Crawshaw L, Kaplan PD. Noninvasive nasal mask ventillation for acute respiratory failure Chest 1994;105:441-444
80.Pfleger A, Theissl B, Oberwaldner B, Zach MS. Self-administered chest physiotherapy in CF: a comparative study of high-pressure PEP an autogenic drainage. Lung 1992; 170: 323-330
81.Phillips GE, Pike S, Jaffe A, Bush A. Comparison of the active cycle of breathing techniques and external high frequency oscillation jacket for clearance of secretions in children with cystic fibrosis. Thorax 1998;53 (Suppl. 4):A61
82.Piper AJ, Parker S, Torzillo PJ, Sullivan CE, Bye PTP. Nocrutnal nasal IPPV stabilizes patients with cystic fibrosis and hypercapnic respiratory failure. Chest 1992;102:846-850
83.Pride NB, Permutt S, Riley RL et al. Determinantsof maximal exspiratory flow from the lungs. J Appl Physiol. 1967. 23:646-62
84.Pryor J A, Webber B A, Hodson M E, Batten J C. Evaluation of the forced exspiration technique as an adjunct to postural drainage in the treatment of cystic fibrosis. Br. Med. J. 2 1979; 417-422
85.Pryor JA, Webber B A. An evaluation of the forced exspiration technique as an adjunct to postural drainage Physiotherapy 65 (1979) 304-307
86.Pryor JA, Parker RA, Webber BA. A comparison of mechanical and manulapercussion to postural drainage in the treatment of cystic fibrosis in adolescents and adults. Physiotherapy 1981;67:140-141
87.Pryor JA, Webber BA, Hodson ME. Effect of chest physiotherapy on oxygen saturation in patients with cystic fibrosis. Thorax 1990;45:77
88.Pryor JA. The forced exspiration technique. From Pryor J (ed) Respiratory care, 1991; Churchill Livingston. 79-100
89.Pryor JA, Webber BA, Hodson ME, Warner JO. The Flutter VRP1 as an adjunct to chest physiotherapy in cystic fibrosis. Respir Med 1994;88:677-681
90.Pryor JA. Physiotherapy for airway clearance in adults. Eur Respir J 1999;14:1418-1424
91.Reidler J, Reade T, Button B, Robertson CF. Inhaled hypertonic saline increases sputum expectoration in cystic fibrosis. J Paediatr Child Health 1996; 32(1) 48-50
92.Reisman J. Conventional postural drainage and percussion- is this still the gold standard? - Pro. Pediatr Pulmonol Suppl. 1994;10:85-86
93.Robinson M, Regnis JA, Bailey DL, King M, Bautovich GJ, Bye PT. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Am J Respir Crit Care Med 1996; 153(5), 1503-1509
94.Robinson M, Hemming AL, Regnis JA, Wong AG, Bailey DL, Bautovich GJ, King M, Bye PT. Effect of increasing dose of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax 1997; 52 (10), 900-903
95.Robinson M, Daviskas E, Eberl S, Baker J, Chan H-K, Anderson SD, Bye PT. The effect of inhaled mannitol on bronchial mucus clearance in CF patients: a pilot study. Eur Respir J 1999; 14: 678-685
96.Robinson W, Waltz DA. FEV1 as a guide to lung transplant referral in young patients with cystic fibrosis. Pediatric Pulmonology 2000;30:198-202
97.Sexauer WP, Shah R. Monitoring of disease progression in CF. New Insights into Cystic Fibrosis 1996;4:7-11
98.Schans CP, Mark ThW, Vries G, Piers, Beekhuis DAP, Dankert-Roelse JE, Postma DS, Koeter GH. Effect of positive exspir. pressure breathing in patients with CF. Thorax 1991;46:252-256
99.Scherer TA, Barandun J, Martinez E, Wanner A, Rubin EM. Effect of High-frequency oral airway and chest wall oscillation and conventional chest physical therapy on expectoration in patients with stable cystic fibrosis. Chest 1998;113:1019-1027
100.Shal W, Bilton D, Dodd M, Webb AK. Effect of exercise and physiotherapy in aiding sputum expectoration in adults with cystic fibrosis. Thorax 1989;44:1006-1008
101.Sigerist HE. A history of medicine. Vol 1.Primitive and archaic medicine. New York, Oxford University Press 1951;p.481
102.Steven MH, Pryor JA, Hodson ME. Physiotherapy versus cough alone in the treatment of cystic fibrosis. N ZJ Physiother 1992;20:31-37
103.Teague WG, Kervin LJ, Diwadkar VV, Scott PH. Nasal Bi-level Positive airway pressure (BLPAP) acutely improves ventilation and oxygen saturation in children with upper airway obstruction. Am Rev Respir Disease 1991;4,143
104.Thomas J, DeHueck A, Kleiner M, Newton J, Crowe J,Mahler S. To vibrate or not to vibrate: usefullnes of the mechanical vibrator for clearing bronchial secretions. Physiother Can 1995;47:120-125
105.Tomkiewicz RP, Bivili A, King M. Effects of oscillating air flow on the rheological properties and clearability of mucous gel simulants. Biorheology 1994;31:511-520
106.Tucker B, Jenkins S. The effect of breathing exercise with body positioning on regional lung ventilation. Aust J Physiother 1996;42:219-227
107.Webber BA. The active cycle of breathing techniques. Cystic Fibrosis News 1990; Aug/Sept: 10-11
108.Webber BA. The active cycle of breathing techniques.Pediatr Pulmonol Suppl. 1992;8:132-133
109.Webber BA. Chest physiotherapy in cystic fibrosis. Thorax 1995;50:1123
110.Webber BA, Pryor JA. Physiotherapy techniques. In: Pryor JA, Webber BA. Physiotherapy for respiratory and cardiac problems. 2nd EdEdinburgh, Churchill Livingston, 1998;pp.137-155
111.West JB. Pulmonary pathophysiology 3rd edn. Williams and Wilkins, Baltimore 1987 pp10-11
112.Wilson GE, Baldwin AL, Walshaw MJ. A comparison of traditional chest physiotherapy with the active cycle of breathing in patients with chronic suppurative lung disease. Eur Respir J 1995;8: Suppl. 19,171S
113.Wollmer P, Ursing K, Midgren B, Eriksson L. Inefficiency of chest percussion in the physical therapy of chronic bronchitis. Eur J Respir Dis 1985;66:233-239
114.Zach MS, Oberwaldner B, Hausler F. Cystic fibrosis: physical exercise versus chest physiotherapy. Archives of Disease in Childhood 1982;57:587-589
115.Zach MS, Berwaldner B, Forche G, Polgar G. Bronchodilator increase airway instability in cystic fibrosis
116.Zach MS, Oberwaldner B. Chest physiotherapy - The Mechanical Approach to Antiinfective Therapy in Cystic Fibrosis. European Journal for Clinical Study and Treatment of Infections Vol 15 (1987) 5,381-384
117.Zach MS, Oberwaldner B. Chest physiotherapy. In: Taussig L, Landau L, eds.Textbook of Pediatric Respiratory Medicine. St Luis, Mosby Inc, 1999; 299-311
A csatlakozáshoz szükséges adatlap megtekintése és kinyomtatása:
Belépési Nyilatkozat